Objective: To constitute a Pharmacy Therapeutic Committee (PTC) and compile, design, develop and publish Owaisi Hospital and Research Centre (OHRC) Hospital Formulary for a tertiary care multi speciality hospital as a patient safety drug delivery system in promoting rational use of drugs. Methodology: PTC Committee was constituted and a descriptive form was designed for acquisition of data for drugs prescribed in respective departments and information pertaining to treatment modalities. The content of monographs to be incorporated was approved by PTC. The latest drug list was obtained from central pharmacy, respective departments/specialties and nursing stations. Subsequently, drugs were classified therapeutically along with USFDA pregnancy risk category; individual drug monographs were prepared, required ancillary information was added and lastly compared with WHO Essential Drugs List (EDL). Copies of the formulary were given to Medical Superintendent, Chief Medical Officer, and Chief Pharmacist and all the departments of Owaisi Group of Hospitals for implementation in the hospital as a tool to promote rational drug use. Results: PTC approved OHRC Hospital Formularyas a handy desk reference was compiled in 530 pages containing 306 generic drugs and FDCs. About 58 drugs were identified as Category A and B, 138 drugs as Category C, D, B/D, A/C and C/D and 7 drugs as Category X. Conclusion: Hospital formulary reflects the current clinical judgment of medical staff ensuring rational drug therapy, controlling drug costs, evidence based prescribing to reduce variation in the levels of treatment; additionally it helps in better inventory control by avoiding zero stock level and to limit the number of brands for each generic drug..
INTRODUCTION
Medicines play a crucial role in the prevention and treatment of diseases. When used correctly, they can offer simple and costeffective solutions to many health problems. A formulary system is the ongoing process through which a health care organization establishes policies regarding the use of drugs, therapies, and drug related products and identifies those that are most medically appropriate and cost-effective to best serve the health interests of a given patient population. 1 Formulary systems are used in many different settings and organizations with policy statements on the use of formularies and formulary systems in hospitals and health care systems. 2, 3 Many products are minor variations of a prototype drug and offer no therapeutic advantage over other drugs that are already available, many new products for therapeutic indications are not relevant to the basic needs of the population. 4 A number of other problems known to exist in most pharmaceutical system are limited drug budgets, increasing number of therapeutic alternatives, improper prescribing and use of medications, presence of unsafe and non-efficacious drugs, lack of unbiased drug information, high costs of handling large number of drugs, drugs of questionable quality on the market. 5, 6 Although National formulary exists in India, its use is limited due to non-availability of updated information. Hence, Hospital formulary system can be an asset for our health care system. 7 A large number of drugs, drug variables and the multiplicity of drugs available for the treatment of diseases and making their use becomes complexity. Lack of co-ordination among the various specialties in treating patients is cited to be a major reason for medication errors and the lack of communication between health care providers contributes to more of adverse events. In its efforts to promote safe and cost-effective use of medicines, World Health Organization (WHO) released the first edition of the WHO Model Formulary in 2002. This formulary is the first global publication to give comprehensive information on all 325 generic drugs contained in the WHO Model List of Essential Medicine. 8 Correct use of this tool will improve patient safety and limit excess medical spending. Therefore, the WHO Model Formulary is primarily intended as a model, for national governments and institutions, as a basis for creating their own formularies. 9 It has been stated that the main reason for developing a formulary is to promote rational prescribing. WHO also recommends in their policy perspectives on medicine that development of formulary system through Drugs and Therapeutic Committee in the hospitals will promote rational use of medicines.
10
A hospital formulary provides information for the hospital staff about drug products approved for use by the Pharmacy and Therapeutic Committee . 11, 12 "The hospital formulary is a continually revised compilation of pharmaceuticals, which reflects the current clinical judgment of the medical staff including physicians, pharmacist and nurses and other experts in the diagnosis, prophylaxis, or treatment of disease and promotion of health". 13 To enhance patient safety and minimize errors there is a need to develop a system mechanism so as to have clear and defined standards of care and protocols that are to be followed. A system therefore is needed to constitute a PTC/DTC (Pharmacy / Drug Therapeutic committee) that function with roles of advisory, educative and policy making body and to develop a Hospital formulary (HF) for the rational-safe, affordable and effective use of drugs and to reduce drug shortages and stock outs.
The study was conducted with the main objective of providing information on the available drugs in the hospital pharmacy to the physicians and the healthcare professionals by developing hospital's own formulary in 
MATERIALS AND METHODS

Study Period
The study was conducted over a period of 6 months from November 2013 to May 2014.
Study Site
The study was conducted in a Tertiary Care multispecialty Hospital, Owaisi Hospital and Research Centre (OHRC), Hyderabad, Telangana.
Hospital Background
OHRC is a 1150 bedded multispecialty tertiary level referral and teaching hospital competently managed by Medical team of dedicated professionals, highly experienced in their respective specialities. Being a teaching hospital, there are no drug information sources present for the students. As the first step, our department started the drug information centre, ADR reporting and medication error monitoring and then worked on developing Hospital Formulary through PTC. By continuously updating the prepared formulary and conducting Drug Utilization Evaluation (DUE) programs, hospital formulary system can be made more effective.
Study Design
A prospective study was conducted to design, develop and publish hospital formulary for a tertiary care referral hospital with an aim to provide drug information to healthcare professionals for adopting standards of best practices for safe and effective drug therapy and better patient care.
Pharmacy and Therapeutic Committee Approval
A meeting was conducted with PTC and other health care professionals about the need and importance of Hospital Formulary. The contents of Hospital Formulary were approved by PTC. There were suggestions to add the general information, emergency drug list, immunological products and vaccines/sera and to incorporate methods/tables for dosage adjustments in renal and hepatic diseases and paediatric dosing. The latest drug list of 1220 formulations including single and combination formulations was obtained from pharmacy, respective departments, specialties and nursing stations. Subsequently drugs were classified therapeutically along with USFDA pregnancy risk category. All drugs present in the drug list were systematically evaluated for their need, efficacy and safety. The Heads of all departments were asked to select the preferable brand/generic names of drugs or they can write drugs that have proven efficacy on their practice which are available/not available in hospital pharmacy. All their suggestions were considered. The doctors clearly informed that from their chosen drugs only cost effective, safe and quality drugs of at least 3 or 4 brands will be selected. The selected drugs were classified according to the British National Formulary as the standard format for the formulary list. Monographs were prepared for all the selected 379 drugs in the hospital pharmacy with the following contents: Synonyms, Therapeutic category, Indication, Pregnancy risk factor, Contraindications, Precautions/Warnings, Adverse reactions, Dosage, Drug interactions, Patient information, Brands available/strength/formulation. Copies of the OHRC hospital formulary were given to all the health-care professionals, medical superintendent, chief medical officer, and chief pharmacist and to pharmacy and therapeutic committee who participated in the first survey. The OHRC hospital formulary was compared with WHO model formulary 2010 on the following parameters.
• Number of drugs present.
• Class wise distribution of drugs.
• Number of brands available for generic drugs in Owaisi Hospital Formulary.
• Pregnancy category of drugs.
• Monograph content.
• Fixed drug combination.
RESULTS
Class wise distribution of the drugs in the OHRC Hospital Formulary with WHO Model Formulary 2010 WHO Model Formulary 2010
In the WHO model list the drugs under the gastrointestinal, cardiovascular, respiratory and central nervous systems were 12, 21, 6 and 24, respectively. Ninety two drugs were from anti-infective class. Drugs falling under endocrine system and obstetrics and gynaecology were 10 each. Musculoskeletal system comprised of 12 drugs and 31 preparations were used for eye, ear and skin disorders. Immunological and vaccines category includes 19 preparations. Fourteen were under the anaesthetic, 12 were under the category of antidotes as illustrated in Table 1 .
OHRC Hospital Formulary
In the prepared hospital formulary, drugs under the gastrointestinal, cardiovascular, respiratory and central nervous systems were 24, 44, 17 and 61 respec-tively, while 41 were anti-infective agents. Endocrine system, obstetrics and gynaecology comprised of 25 and 6 drugs, respectively. Musculoskeletal system, eye disorders, Ear and skin disorders consisted of 25, 14 medicines, respectively. 10 drugs were anaesthetics, 4 antidotes respectively. 21 immunological and vaccines were included as shown in Table 1 and Figure 1 .
Monograph content
The WHO Model Formulary contains Patient Information and cost which was not included in OHRC hospital formulary as according to Drug Price Control (DPCO) Order there is always a variance in the cost depending on the drug products or medicament used, the manufacturing company, the availability of product in the market, the treatment regimen of the patient etc. The cost of a drug varies hence, cost is not included in our hospital formulary though it is considered as an important parameter and supplementary information as cost effectiveness and cost benefit analysis methods are often used to prescribe a drug. WHO Model Formulary monographs does not contain mechanism of action of the drugs which was included Cardiovascular system 21 44
Respiratory system 6 17
Central nervous system 24 61
Antiinfectives
41
Endocrine system 10 25
Obstetrics, Gynecology and Urinary tract disorders 10 6
Nutrition and blood products 22 -
Musculoskeletal and joint disease 12 25
Eye, Ear, Skin 31 14
Immunological Products and Vaccines
21
Anaesthetics
10
Antidotes 12 4
(Numbers mentioned indicates the drugs of particular therapeutic category present in WHO, National drug list and prepared hospital formulary) in OHRC Hospital Formulary out of the authors' interest in order to provide complete information to the Health Care Team.
Drugs to be avoided or used with caution in pregnancy
Drugs should be prescribed in pregnancy only if the expected benefits to the mother are thought to be greater than the risk to the foetus. The WHO model formulary consists of 199 drugs and OHRC Hospital Formulary consists of 145 drugs, which should be avoided or used with caution in pregnancy. The number of drugs under each pregnancy category according to USFDA is shown in Table 3 . While evaluating, it was found that the more number of drugs and drug combinations were present in the OHRC hospital formulary. The number of brands available for individual drug was higher than recommended.
DISCUSSION
CONCLUSION
The OHRC hospital formulary can be used as a vehicle to provide information to the physicians and healthcare professionals about the available drugs in the hospital pharmacy and can be used as a tool to rationalize the medicines used in the hospital. Implementation of hospital formulary helps in better inventory control by avoiding zero stock level. Hospital formulary thus reflects the current clinical judgment of medical staff 14, 15 ensuring rational drug therapy, controlling drug costs and promotes high quality; evidence based prescribing thus reducing variation in the levels of treatment provided to patients 16 and must be present in a complete, concise, updated and easy to use desk reference. 
